Healthcare News & Events
This Week’s Healthcare Market Update
DNB//Back Bay’s weekly bulletin provides IPOs, follow-on offerings, M&A, and venture financing activity across the US and EU
The Most Notable Product Approvals of 2023
Data-Driven Strategy + Investment Banking
Back Bay is the only life sciences group that integrates seasoned strategic insight with investment banking capabilities to provide comprehensive guidance to global life sciences companies and their investors. Our team has the expertise to advise clients through complex business, scientific and financial challenges.
Boutique Feel + Global Reach
Global biotech. Pharmaceutical. Medical Device Companies. Investors. Academic centers of technology development. Government incubators. These are the organizations that rely on Back Bay for strategic guidance and responsive client service across their commercial, R&D, corporate business development and investment banking opportunities in the US and around the world.
We’re pleased to provide a snapshot of some of our recent transactions and projects.
Back Bay advisors are trusted partners who combine insights generated from in-depth scientific, clinical and financial analysis with exceptional transaction execution capabilities. The result is tailored advice for every phase of the product life cycle.
600+ projects in BioPharma and MedTech
From early-stage candidates to global brand leaders, we work with companies across every stage, sector, geography and disease area to position assets for maximum value and impact. With 600+ life science projects, Back Bay delivers a keen understanding of the value of new technologies, medicines and scientific approaches.Actionable Life Sciences Solutions
At Back Bay, we understand the dizzying pace of change in physician, patient and payor behaviors, competitive science and technologies, investor approaches and market demands. The life sciences industry is complicated. Back Bay advisors provide solutions that are advantageous and actionable.Data Driven Strategies
Back Bay Life Science Advisors are industry leaders for a reason—we know how to turn data into knowledge. All of our assignments leverage a comprehensive range of data sources backed by the analytic capabilities of our team. When it comes to the critical decisions that drive value, we can offer clear and unbiased advice.
FEATURED TRANSACTIONS:
Life Sciences Development and Commercialization
We guide biotech, pharmaceutical and medical technology companies and their investors on the development, commercialization, growth and maintenance of market share, by providing the insight needed to drive growth and create value. Together we can capitalize on opportunity, increase shareholder value and improve patient care.
Latest Back Bay White Papers on Biopharma, MedTech Commercialization and Transactions
View our Transaction Highlights
This past year has been one of tremendous growth and progress for Back Bay Life Science Advisors. We served as advisors to global biopharma and medtech companies, guided them as they navigated the complexities and scientific and transactional challenges of bringing new treatments to the market and continued our work of paving a way toward the next generation of life science breakthroughs. We are proud to present this snapshot of our project work and transaction highlights from 2021.